c-Myc protein expression is not an independent prognostic predictor in cervical squamous cell carcinoma
AUTOR(ES)
Brenna, S.M.F., Zeferino, L.C., Pinto, G.A., Souza, R.A., Andrade, L.A.L., Vassalo, J., Martinez, E.Z., Syrjänen, K.J.
FONTE
Brazilian Journal of Medical and Biological Research
DATA DE PUBLICAÇÃO
2002-04
RESUMO
The c-myc protein is known to regulate the cell cycle, and its down-regulation can lead to cell death by apoptosis. The role of c-myc protein as an independent prognostic determinant in cervical cancer is controversial. In the present study, a cohort of 220 Brazilian women (mean age 53.4 years) with FIGO stage I, II and III (21, 28 and 51%, respectively) cervical squamous cell carcinomas was analyzed for c-myc protein expression using immunohistochemistry. The disease-free survival and relapse-rate were analyzed using univariate (Kaplan-Meier) survival analysis for 116 women who completed the standard FIGO treatment and were followed up for 5 years. Positive c-myc staining was detected in 40% of carcinomas, 29% being grade 1, 9% grade 2, and 2% grade 3. The distribution of positive c-myc according to FIGO stage was 19% (17 women) in stage I, 33% (29) in stage II, and 48% (43) in stage III of disease. During the 60-month follow-up, disease-free survival in univariate (Kaplan-Meier) survival analysis (116 women) was lower for women with c-myc-positive tumors, i.e., 60.5, 47.5 and 36.6% at 12, 36, and 60 months, respectively (not significant). The present data suggest that immunohistochemical demonstration of c-myc does not possess any prognostic value independent of FIGO stage, and as such is unlikely to be a useful prognostic marker in cervical squamous cell carcinoma.
Documentos Relacionados
- Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.
- C-myc oncogene expression in anal squamous neoplasia.
- Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.
- Expression of c-myc is not critical for cell proliferation in established human leukemia lines
- Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.